These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 1442614

  • 1. Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris.
    Sedgwick ML, Rasmussen HS, Cobbe SM.
    Am J Cardiol; 1992 Dec 01; 70(18):1432-7. PubMed ID: 1442614
    [Abstract] [Full Text] [Related]

  • 2. Effects of the new class III antiarrhythmic drug dofetilide on the atrial and ventricular intracardiac monophasic action potential in patients with angina pectoris.
    Sedgwick ML, Dalrymple I, Rae AP, Cobbe SM.
    Eur Heart J; 1995 Nov 01; 16(11):1641-6. PubMed ID: 8881860
    [Abstract] [Full Text] [Related]

  • 3. Effect of dofetilide on cardiac repolarization in patients with ventricular tachycardia. A study using simultaneous monophasic action potential recordings from two sites in the right ventricle.
    Yuan S, Wohlfart B, Rasmussen HS, Olsson S, Blomström-Lundqvist C.
    Eur Heart J; 1994 Apr 01; 15(4):514-22. PubMed ID: 8070479
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dofetilide promotes repolarization abnormalities in perfused Guinea-pig heart.
    Osadchii OE.
    Cardiovasc Drugs Ther; 2012 Dec 01; 26(6):489-500. PubMed ID: 22918600
    [Abstract] [Full Text] [Related]

  • 7. Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study Group.
    Bashir Y, Thomsen PE, Kingma JH, Møller M, Wong C, Cobbe SM, Jordaens L, Campbell RW, Rasmussen HS, Camm AJ.
    Am J Cardiol; 1995 Nov 15; 76(14):1040-4. PubMed ID: 7484858
    [Abstract] [Full Text] [Related]

  • 8. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.
    Bargheer K, Bode F, Klein HU, Trappe HJ, Franz MR, Lichtlen PR.
    Eur Heart J; 1994 Oct 15; 15(10):1409-14. PubMed ID: 7821321
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group.
    Nørgaard BL, Wachtell K, Christensen PD, Madsen B, Johansen JB, Christiansen EH, Graff O, Simonsen EH.
    Am Heart J; 1999 Jun 15; 137(6):1062-9. PubMed ID: 10347332
    [Abstract] [Full Text] [Related]

  • 10. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT, Nademanee K, Antimisiaris M, Pacifico A, Pruitt C, Godfrey R, Singh BN.
    Circulation; 1993 Sep 15; 88(3):1072-82. PubMed ID: 8353869
    [Abstract] [Full Text] [Related]

  • 11. Dispersion of ventricular repolarization in left ventricular hypertrophy: influence of afterload and dofetilide.
    Gillis AM, Mathison HJ, Kulisz E, Lester WM.
    J Cardiovasc Electrophysiol; 1998 Sep 15; 9(9):988-97. PubMed ID: 9786080
    [Abstract] [Full Text] [Related]

  • 12. Selective Ik blocker almokalant exhibits class III--specific effects on the repolarization and refractoriness of the human heart: a study of healthy volunteers using right ventricular monophasic action potential recordings.
    Darpö B, Vallin H, Almgren O, Bergstrand R, Insulander P, Edvardsson N.
    J Cardiovasc Pharmacol; 1995 Oct 15; 26(4):530-40. PubMed ID: 8569212
    [Abstract] [Full Text] [Related]

  • 13. Effects of dofetilide on electrical dispersion and arrhythmias in post-infarcted anesthetized dogs.
    D'Alonzo AJ, Sewter JC, Darbenzio RB, Hess TA.
    Basic Res Cardiol; 1995 Oct 15; 90(5):424-34. PubMed ID: 8585865
    [Abstract] [Full Text] [Related]

  • 14. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
    Van Opstal JM, Leunissen JD, Wellens HJ, Vos MA.
    Eur J Pharmacol; 2001 Jan 19; 412(1):67-76. PubMed ID: 11166738
    [Abstract] [Full Text] [Related]

  • 15. Differential effect of dofetilide on ventricular repolarization during steady state and during restitution in vivo.
    Todt H, Zojer N, Schütz W.
    J Cardiovasc Pharmacol; 1994 Dec 19; 24(6):1010-3. PubMed ID: 7898064
    [Abstract] [Full Text] [Related]

  • 16. Electrophysiological, rate dependent, and autonomic effects of the class III antiarrhythmic almokalant after myocardial infarction in the pig.
    Tuininga YS, De Langen CD, Crijns HJ, Wiesfeld AC, Mook PH, Bel KJ, Lie KI.
    Pacing Clin Electrophysiol; 1996 May 19; 19(5):802-10. PubMed ID: 8734747
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dynamic analysis of dofetilide-induced changes in ventricular repolarization.
    Lande G, Maison-Blanche P, Fayn J, Ghadanfar M, Coumel P, Funck-Brentano C.
    Clin Pharmacol Ther; 1998 Sep 19; 64(3):312-21. PubMed ID: 9757155
    [Abstract] [Full Text] [Related]

  • 20. Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.
    Blaauw Y, Schotten U, van Hunnik A, Neuberger HR, Allessie MA.
    Cardiovasc Res; 2007 Jul 01; 75(1):89-98. PubMed ID: 17466958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.